News 2019

« BACK

Pharmacology



Results 21 - 40 of 162.


Health - Pharmacology - 19.11.2019
Technique to preserve sexual function after prostate cancer surgery
A UCLH and UCL led trial of a technique to preserve men's sexual potency after prostate cancer surgery has begun to recruit participants across the UK. The trial of the NeuroSAFE procedure - designed to avoid the removal during surgery of nerves near the prostate which are important for sexual function - is being led by UCLH consultant urological surgeon Greg Shaw and sponsored by UCL.

Life Sciences - Pharmacology - 19.11.2019
Ayahuasca compound changes brainwaves to vivid ’waking-dream’ state
Scientists have peered inside the brain to show how taking DMT affects human consciousness by significantly altering the brain's electrical activity. DMT (or dimethyltryptamine) is one of the main psychoactive constituents in ayahuasca, the psychedelic brew traditionally made from vines and leaves of the Amazon rainforest.

Pharmacology - 18.11.2019
Scientists and schoolkids find family soups have antimalarial properties
London schoolchildren have found that some of their families' soup recipes have antimalarial properties, with the help of Imperial scientists. Researchers from Imperial College London helped the schoolchildren test their family soup broths for activity against the malaria parasite. We may have to look beyond the chemistry shelf for new drugs, and natural remedies shouldn't be off our watch list, as artemisinin shows.

Health - Pharmacology - 18.11.2019
Scientists make vampire bats ’glow’ to simulate vaccine spread
Scientists have used 'glowing' fluorescent gel to estimate the potential effectiveness of spreadable vaccines to control diseases in wild bats. The study - led by researchers at the Universities of Glasgow and Michigan, and published today in Nature Ecology and Evolution - found that a low effort vaccination programme could substantially reduce rabies transmission in wild vampire bats, thereby reducing the risk of lethal infections in humans and livestock.

Pharmacology - Health - 15.11.2019
Link between inflammation and mental sluggishness shown in new study
Scientists at the University of Birmingham in collaboration with the University of Amsterdam have uncovered a possible explanation for the mental sluggishness that often accompanies illness. An estimated 12M UK citizens have a chronic medical condition, and many of them report severe mental fatigue that they characterize as ‘sluggishness' or ‘brain fog'.

Pharmacology - Chemistry - 14.11.2019
Could synthetic molecules provide a general treatment for Cystic Fibrosis?
A new treatment for lung disease in cystic fibrosis (CF) for which there remains no cure could potentially benefit all patients, according to a University of Bristol study published in Chemical Science. The findings are an important step towards a new therapy addressing the fundamental cause of cystic fibrosis.

Health - Pharmacology - 13.11.2019
Bionic pacemaker slows progression of heart failure
Using brain circuits made in silicon, scientists have alleviated symptoms of heart failure by reinstating the body's natural heart rhythm. This study published in The Journal of Physiology today [Wednesday 13 November] holds great potential for designing more effective pacemakers in the future. In the UK alone, around 900,000 people are living with heart failure and almost 1.4 million have survived a heart attack.

Health - Pharmacology - 12.11.2019
Old Joe to turn blue to mark World Antibiotic Awareness Week
The face of the University of Birmingham's ‘Old Joe' Clock tower will be lit blue to shine a light on the work scientists are doing to discover new ways to prevent and treat drug-resistant bacterial infections. The clock will turn blue during World Antibiotic Awareness Week 2019, which runs from 18 - 24 November, and is organised by the World Health Organization (WHO) to increase global awareness of antibiotic resistance and to encourage best practices among the general public, health workers and policy makers to avoid the further emergence and spread of antibiotic resistance.

Health - Pharmacology - 11.11.2019
Pioneering new ‘smart needle’ could revolutionise cancer diagnosis
Scientists have developed a pioneering new technique that can detect and diagnose one of the most common types of cancer within seconds - using light. A multidisciplinary team of experts has developed a ground-breaking ‘smart needle' probe that uses light to pinpoint cancerous tissues or cells almost instantaneously.

Health - Pharmacology - 08.11.2019
UCL hosts minister as part of Tomorrow’s Engineers Week
Universities Minister Chris Skidmore MP visited the UCL Institute of Healthcare Engineering (IHE) Autumn Research Symposium today as part of Tomorrow's Engineers Week. Mr Skidmore met Professor Becky Shipley, Director of the IHE, who with her team demonstrated the REANIMATE project (REAlistic Numerical Image-based Modelling of biological Tissue substratEs), which is a virtual modelling technique that creates highly detailed 3D models of individual cancerous tumours and simulates the delivery of drugs into them.

Pharmacology - Health - 08.11.2019
Immersion in virtual reality scenes of the Arctic helps to ease people’s pain
Watching immersive 3D videos of icy Arctic scenes helps to relieve burning pain and could hold hope for treating chronic pain, a study has found. Scientists from Imperial College London have found that using virtual reality headsets could combat increased sensitivity to pain, by immersing people in scenes of icebergs, frigid oceans and sprawling icescapes.

Health - Pharmacology - 07.11.2019
Potential new target for treatment of inflammatory disease
Researchers led by the University of Birmingham have found a potential new target to treat inflammatory disease. The research, led by scientists at the University of Birmingham's Institute of Inflammation and Ageing , Institute of Cardiovascular Sciences, and Institute of Metabolism and Systems Research, publishes today in Cell Metabolism.

Health - Pharmacology - 07.11.2019
Simple blood test could better predict both kidney disease and cardiovascular risk
Researchers have found a better way to test for kidney disease using a simple blood test that is affordable and although it is available in NHS laboratories is not yet widely used. Kidney disease and cardiovascular risk could be easier to predict using a simple blood test.

Health - Pharmacology - 07.11.2019
Flu shot can provide effective immunity for people living with HIV
People who are being treated for HIV can gain effective protection against seasonal flu with the influenza (flu) vaccine, new findings confirm. Since people living with HIV can have an impaired immune system and may be at higher risk of serious illness from flu, they are recommended to get the seasonal influenza vaccine every year.

Health - Pharmacology - 01.11.2019
New Glasgow Cancer Tests for research and clinical trials
The Glasgow Precision Oncology Laboratory (GPOL) at the University of Glasgow has developed a ground-breaking new cancer test for research and clinical trials that could ultimately change the way cancer medicine is delivered. The Glasgow Cancer Tests are a suite of affordable solid tumour and blood cancer tests, developed specifically to enable patients to benefit from real-world precision medicine-based cancer treatments.

Health - Pharmacology - 31.10.2019
Measles causes ’immune amnesia’ leaving us vulnerable to other diseases
Scientists have shown how measles causes long-term damage to the immune system, leaving people vulnerable to other infections. The international team, which includes the Wellcome Sanger Institute, the University of Amsterdam and Imperial College London, revealed that the measles virus deletes part of the immune system's memory, removing previously existing immunity to other infections, in both humans and ferrets.

Pharmacology - Health - 23.10.2019
20th century views and responses to drug use are no longer fit for purpose
A report from The Lancet calls for a new international approach to drug use - using evidence-based policies, which adapt faster, and respond more humanely and effectively to new drugs and their changing availability and patterns of use. The five-paper Series publishes as the opioid crisis continues, cannabis legalisation expands, global stimulant problems grow, and the number of new psychoactive substances (NPS) identified continues to increase.

Health - Pharmacology - 23.10.2019
Trial will look at new Parkinson’s treatment for frequent falls
Researchers have been awarded funding to trial a new treatment for frequent falls in patients with advanced Parkinson's. In Parkinson's disease, some parts of the brain begin to deteriorate, leading to symptoms including balance problems, which can increase the chances of falls. A team from Imperial College London and Imperial College Healthcare NHS Trust have been awarded 250,000 from the Medical Research Council (MRC) to trial a surgical implant that alters nerve activity, which could improve movement and reduce the number of falls.

Health - Pharmacology - 21.10.2019
Detecting the (almost) undetectable: new cancer alliance
UCL research teams are part of a new transatlantic research alliance to develop radical new strategies and technologies to detect cancer at its earliest stage. Cancer Research UK is the lead funder of the International Alliance for Cancer Early Detection (ACED), a 55m investment bringing together UCL, Canary Center at Stanford University, the University of Cambridge, the OHSU Knight Cancer Institute, and the University of Manchester.

Health - Pharmacology - 21.10.2019
Researchers identify a new way to target treatment-resistant cancers
An international team of researchers has found a different way cancer becomes resistant to chemotherapy, suggesting a new target for drugs. Chemotherapy kills cancers cells by preventing them from multiplying and by inducing ‘cell death', a natural process that can be enhanced with drugs. One form of cell death, called ferroptosis - iron-dependent cell death - is caused by the degradation of fats (lipids) that make up the cell membrane.

This site uses cookies and analysis tools to improve the usability of the site. More information. |